市場調查報告書
商品編碼
1029264

脈絡膜新生血管的全球市場 (2021-2026年):產業趨勢、市場佔有率、市場規模、成長預測、市場機會

Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 144 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球脈絡膜新生血管的市場規模2020年表現53億美元的規模,在預測期間中預計以約7%的年複合成長率成長。

由於年齡相關性黃斑變性 (ARMD)、眼組織胞漿菌病、病理性近視、血管樣條紋、脈絡膜撕裂以及脈絡膜和視網膜炎性疾病的患病率不斷上升,市場經歷成長。此外,越來越多的老年人口更容易受到嚴重健康狀況的影響,這是推動市場成長的另一個關鍵因素。日益採用聯合藥物,以及長效抗VEGF藥物的導入,推動全球對CNV治療的需求。其他因素例如改善醫療保健基礎設施和增加對研發(R&D)活動的投資,也促進了市場的成長。

本報告提供全球脈絡膜新生血管的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19)以及其他的市場影響因素分析,市場規模的變化、預測,產品類型、診斷區分、治療區分、用途、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 序文

第2章 調查範圍、調查手法

第3章 摘要整理

第4章 簡介

第5章 世界市場趨勢

  • 市場概要
  • 市場成果
  • COVID-19的影響

第6章 市場分析、預測:各產品類型

  • 靜脈注射
  • 玻璃體內給藥

第7章 市場分析、預測:各診斷種類

  • 螢光血管造影術 (FA)
  • 靛氰綠 (ICG) 血管造影術
  • 頻域光學同調斷層掃瞄技術 (SD-OCT)
  • 其他

第8章 市場分析、預測:各治療種類

  • 血管新生抑制劑注射
  • 光線動態療法
  • 雷射光凝固術
  • 低輻射劑量照射療法
  • 外科手術

第9章 市場分析、預測:各用途

  • 極度近視
  • 惡性近視變性
  • 老齡化變性

第10章 市場分析、預測:各地區、主要國家

  • 北美
  • 亞太地區
  • 歐洲
  • 南美
  • 中東、非洲

第11章 SWOT分析

第12章 價值鏈分析

第13章 波特的五力分析

第14章 價格分析

第15章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • Bausch Health Companies Inc.
    • Bayer AG
    • Gilead Sciences, Inc.
    • F. Hoffmann-La Roche AG
    • MaaT Pharma
    • Novartis AG
    • Pfizer Inc.
    • Quark Pharmaceuticals Inc.(SBI ALApharma Co., Limited)
    • Regeneron Pharmaceuticals Inc.
    • Sanwa Kagaku Kenkyusho Co. Ltd.(SUZUKEN CO., LTD.)
目錄
Product Code: SR1020F214_Report

The global choroidal neovascularization market reached a value of US$ 5.3 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.

The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market. However, with the spread of the coronavirus disease (COVID-19), the healthcare systems of various countries have become overburdened. Consequently, doctors are focusing on patient selection, safe injection techniques and proper sterilization to prevent the risk of contracting and transmitting the disease. In a non-emergency case, they are either rescheduling and postponing the follow-up appointments or providing remote monitoring solutions using telehealth to patients with severe conditions.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global choroidal neovascularization market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, type of diagnosis, treatment type and application.

Breakup by Product Type:

  • Intravenous
  • Intravitreal

Breakup by Type of Diagnosis:

  • Fluorescein Angiography (FA)
  • Indocyanine Green (ICG) Angiography
  • Spectral Domain Optical Coherence Tomography (OCT)
  • Others

Breakup by Treatment Type:

  • Angiogenesis Inhibitors Injection
  • Photodynamic Therapy
  • Laser photocoagulation
  • Low-dose Radiation Therapy
  • Surgery

Breakup by Application:

  • Extreme Myopia
  • Malignant Myopic Degeneration
  • Age-Related Developments

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.). Key Questions Answered in This Report:

  • How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global choroidal neovascularization market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the type of diagnosis?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global choroidal neovascularization market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Choroidal Neovascularization Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Intravenous
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravitreal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type of Diagnosis

  • 7.1 Fluorescein Angiography (FA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Indocyanine Green (ICG) Angiography
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spectral Domain Optical Coherence Tomography (OCT)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Treatment Type

  • 8.1 Angiogenesis Inhibitors Injection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Photodynamic Therapy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Laser Photocoagulation
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Low-dose Radiation Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Extreme Myopia
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Malignant Myopic Degeneration
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Age-Related Developments
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Gilead Sciences, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 MaaT Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Regeneron Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
  • Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2020
  • Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2020
  • Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2020
  • Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2020
  • Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
  • Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
  • Figure 87: Global: Choroidal Neovascularization Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
  • Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million US$), 2021-2026
  • Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
  • Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Choroidal Neovascularization Market Structure
  • Table 8: Global: Choroidal Neovascularization Market: Key Players